TLR3 and breast carcinoma: Further mechanistic studies with BP nanoparticles revealed the activation of Toll-like receptor 3 (TLR3)-mediated innate-to-adaptive immune signaling as the mechanism of tumor growth and metastasis inhibition in multiple mouse breast cancer models, with no discernible toxicity observed in the mice (Korangath et al., 2024).